Professor, Anaesthesia-Children's Hospital, Harvard Medical School
Anesthesiology
Dr. Daniel S. Kohane, MD
|
|
Give Review
Dr. Daniel S. Kohane is an expert in the field of Anesthesiology. He studied medicine at Boston University School of Medicine. Boston University School of Medicine has a rank of 30 in research and a 52 in primary care Daniel Kohane has written publications. He has 100 publications published with PubMed. The lastest publication is: 'Vanilloid receptor agonists potentiate the in vivo local anesthetic activity of percutaneously injected site 1 sodium channel blockers.'
Publications
- Selective binding of C-6 OH sulfated hyaluronic acid to the angiogenic isoform of VEGF165.
- New Strategies in Cancer Nanomedicine.
- NIR-Triggered Drug Delivery by Collagen-Mediated Second Harmonic Generation.
- Aptamer photoregulation in vivo.
- Clinicians' perspectives on the use of drug-eluting contact lenses for the treatment of glaucoma.
- A two-component pre-seeded dermal-epidermal scaffold.
- Prospects for near-infrared technology in remotely triggered drug delivery.
- Photothermally Targeted Thermosensitive Polymer-Masked Nanoparticles.
- Multivesicular liposomal bupivacaine at the sciatic nerve.
- Near-infrared-actuated devices for remotely controlled drug delivery.
- In vivo performance of a drug-eluting contact lens to treat glaucoma for a month.
- Prevention of peritoneal adhesions using polymeric rheological blends.
- SDF-1α in Glycan Nanoparticles Exhibits Full Activity and Reduces Pulmonary Hypertension in Rats.
- Photoswitchable nanoparticles for in vivo cancer chemotherapy.
- Photoactive Electrospun Fibers for Inducing Cell Death.
- A photo-triggered layered surface coating producing reactive oxygen species.
- Long-lasting antifouling coating from multi-armed polymer.
- Enhanced Photothermal Effect of Plasmonic Nanoparticles Coated with Reduced Graphene Oxide.
- Biodegradable Mesostructured Polymer Membranes.
- Topical Drug Formulations for Prolonged Corneal Anesthesia.
- Microdevices for Nanomedicine.
- Local toxicity from local anesthetic polymeric microparticles.
- Controlled-release systems in neuropathic pain.
- Synthetic Ligand-Coated Magnetic Nanoparticles for Microfluidic Bacterial Separation from Blood.
- Formulations for trans-tympanic antibiotic delivery.
- Modular 'Click-in-Emulsion' Bone-Targeted Nanogels.
- Benchtop fabrication of microfluidic systems based on curable polymers with improved solvent compatibility.
- Materials to clinical devices: technologies for remotely triggered drug delivery.
- Nanocomposite Gold-Silk Nanofibers.
- Macroporous nanowire nanoelectronic scaffolds for synthetic tissues.
- Shedding light on nanomedicine.
- The Smartest Materials: The Future of Nanoelectronics in Medicine.
- Electrospun Drug-Eluting Sutures for Local Anesthesia.
- An in situ cross-linking hybrid hydrogel for controlled release of proteins.
- Photoswitchable Nanoparticles for Triggered Tissue Penetration and Drug Delivery.
- Nanogel scavengers for drugs: Local anesthetic uptake by thermoresponsive nanogels.
- Nanoparticles targeting the infarcted heart.
- Nanowired three-dimensional cardiac patches.
- Liposomes for HIV prophylaxis.
- Hydroxyapatite for keratoprosthesis biointegration.
- Microgels for Efficient Protein Purification.
- Surface modification and drug delivery for biointegration.
- Nanotechnology for surgeons.
- Elasticity and safety of alkoxyethyl cyanoacrylate tissue adhesives.
- A prototype antifungal contact lens.
- Magnetically triggered nanocomposite membranes: a versatile platform for triggered drug release.
- Combinatorial extracellular matrices for human embryonic stem cell differentiation in 3D.
- Prolonged sensory-selective nerve blockade.
- Rheological blends for drug delivery. I. Characterization in vitro.
- Rheological blends for drug delivery. II. Prolongation of nerve blockade, biocompatibility, and in vitro-in vivo correlations.
- Photo-targeted nanoparticles.
- Three-dimensional conductive constructs for nerve regeneration.
- A magnetically triggered composite membrane for on-demand drug delivery.
- A drug-eluting contact lens.
- Contact lenses for drug delivery.
- Prolonged duration local anesthesia with minimal toxicity.
- Intracellular drug delivery by poly(lactic-co-glycolic acid) nanoparticles, revisited.
- Effect of chemical permeation enhancers on nerve blockade.
- Spray-dried lipid-hyaluronan-polymethacrylate microparticles for drug delivery in the peritoneum.
- Microparticles for inhalational delivery of antipseudomonal antibiotics.
- Polymeric biomaterials in tissue engineering.
- Local myotoxicity from sustained release of bupivacaine from microparticles.
- Inhaled agonists of soluble guanylate cyclase induce selective pulmonary vasodilation.
- Antifungal hydrogels.
- Photocrosslinkable hydrogel for myocyte cell culture and injection.
- In situ cross-linkable hyaluronan hydrogels containing polymeric nanoparticles for preventing postsurgical adhesions.
- Microparticles and nanoparticles for drug delivery.
- Tetrodotoxin for prolonged local anesthesia with minimal myotoxicity.
- Hyaluronic acid-based microgels and microgel networks for vocal fold regeneration.
- Peritoneal application of chitosan and UV-cross-linkable chitosan.
- Biodegradable polymeric microspheres and nanospheres for drug delivery in the peritoneum.
- Tissue injury from tricyclic antidepressants used as local anesthetics.
- Prolonged duration local anesthesia with lipid-protein-sugar particles containing bupivacaine and dexamethasone.
- Complex coacervates for thermally sensitive controlled release of flavor compounds.
- Engineering vascularized skeletal muscle tissue.
- Case records of the Massachusetts General Hospital. Case 16-2005. A nine-year-old girl with headaches and hypertension.
- Injectable microparticle-gel system for prolonged and localized lidocaine release. I. In vitro characterization.
- Injectable microparticle-gel system for prolonged and localized lidocaine release. II. In vivo anesthetic effects.
- pH-triggered microparticles for peptide vaccination.
- Microparticulate formulations for the controlled release of interleukin-2.
- Effect of excipient composition on the biocompatibility of bupivacaine-containing microparticles at the sciatic nerve.
- pH-triggered release of macromolecules from spray-dried polymethacrylate microparticles.
- Effectiveness of muscimol-containing microparticles against pilocarpine-induced focal seizures.
- Biocompatibility of lipid-protein-sugar particles containing bupivacaine in the epineurium.
- BID mediates neuronal cell death after oxygen/ glucose deprivation and focal cerebral ischemia.
- High concentrations of adrenergic antagonists prolong sciatic nerve blockade by tetrodotoxin.
- Effects of adrenergic agonists and antagonists on tetrodotoxin-induced nerve block.
- Sciatic nerve blockade with lipid-protein-sugar particles containing bupivacaine.
- The local anesthetic properties and toxicity of saxitonin homologues for rat sciatic nerve block in vivo.
- Vanilloid receptor agonists potentiate the in vivo local anesthetic activity of percutaneously injected site 1 sodium channel blockers.
- Sciatic nerve blockade in infant, adolescent, and adult rats: a comparison of ropivacaine with bupivacaine.
- A re-examination of tetrodotoxin for prolonged duration local anesthesia.
- Stress-induced proteins in aortic smooth muscle cells and aorta of hypertensive rats.
- Lipid-sugar particles for intracranial drug delivery: safety and biocompatibility.
- Local anesthetics inhibit uterine activity in vitro. Possible application on preterm labor prevention and treatment.
- Prolonged duration local anesthesia from tetrodotoxin-enhanced local anesthetic microspheres.
- In vivo evaluation of tetrahedral amorphous carbon.
- Site 1 sodium channel blockers prolong the duration of sciatic nerve blockade from tricyclic antidepressants.
- Prolongation of sciatic nerve blockade by in situ cross-linked hyaluronic acid.
Schools
Boston University School Of Medicine
Children39s Hospital Boston
Mass General Hospital
Doctors Specialties
- Pediatric Critical Care Medicine
- Anesthesiology
Accepted Insurances
Education
-
Boston Children's Hospital -
Massachusetts General Hospital -
Boston University School of Medicine
Drug Facts
| NPI NUMBER | 1235399734 | |
| NPPES Provider LastName | KOHANE | |
| NPPES Provider FirstName | DANIEL | |
| NPPES Provider ZIPCode | 117023027 | |
| NPPES Provider State | NY | |
| Specialty Description | Pain Management | |
| Total Claim Count | 1846.0 | |
| Distinct Opioid Count | 14.0 | |
| Opioid Claim Count | 938.0 | |
| Percent Opioid Claims | 50.81 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1235399734 |
| Last Name Of The Provider | KOHANE |
| First Name Of The Provider | DANIEL |
| View All |
Similar Doctors
|
|
Dr. Pacifico M. Tuason Jr., MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Gregory E. Ginsburg, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Robert A. Finkelstein, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. James B. McAlvin, MD |
|
|
Dr. Robert J. Graham, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jie Zhou, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Michael J. Whalen, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Joseph J. Frassica, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Derek Rosner, DO |
|
|
Dr. Amir Islami-Manuchehry, MD |